Non-kinase Orchestrated VEGFR2–ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy

Cancer Research · Published 2026-07-23 · DOI 10.1158/0008-5472.can-25-5811

Authors (17)

Wengui Shi, Zhijian Ma, Qiaoyan Wang, Zijiao Yang, Huiming Zhao, Xueling Zhang, Tongyu Zhang, Baoyuan Tang, Yuman Dong, Yiwei Dai, Xiangyan Jiang, Long Qin, Bo Long, Huinian Zhou, Zeyuan Yu, Qianlin Gu, Zuoyi Jiao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shi, W., Ma, Z., Wang, Q., et al. (2026). Non-kinase Orchestrated VEGFR2–ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy. Cancer Research. https://doi.org/10.1158/0008-5472.can-25-5811

Related articles